Miyata A, Jiang L, Dahl R D, Kitada C, Kubo K, Fujino M, Minamino N, Arimura A
U.S.-Japan Biomedical Research Laboratories, Tulane University Hebert Center, Belle Chasse, LA 70037.
Biochem Biophys Res Commun. 1990 Jul 31;170(2):643-8. doi: 10.1016/0006-291x(90)92140-u.
A novel neuropeptide with 38 residues (PACAP38) was isolated from ovine hypothalamic tissues using the pituitary adenylate cyclase activation in rat pituitary cell cultures as a parameter of the biological activity (Miyata et al, Biochem. Biophys. Res. Commun. 164, 567-574, 1989). From the side fractions obtained during the purification of PACAP38, a shorter form peptide with 27 residues corresponding to the N-terminal 27 amino acids of PACAP38 and amidated C-terminus was isolated and named as PACAP27. Synthetic PACAP27 showed a biological activity of adenylate cyclase stimulation comparable to PACAP38. Moreover PACAP27 which shows a considerable homology with vasoactive intestinal polypeptide (VIP) demonstrated a similar vasodepressor activity as VIP, but the adenylate cyclase stimulating activity was about 1000 times greater than VIP.
利用大鼠垂体细胞培养中垂体腺苷酸环化酶的激活作为生物活性参数,从绵羊下丘脑组织中分离出一种含38个氨基酸残基的新型神经肽(PACAP38)(宫田等人,《生物化学与生物物理研究通讯》164,567 - 574,1989年)。从PACAP38纯化过程中获得的侧馏分中,分离出一种含27个氨基酸残基的较短形式肽,其对应于PACAP38的N端27个氨基酸且C端酰胺化,命名为PACAP27。合成的PACAP27显示出与PACAP38相当的腺苷酸环化酶刺激生物活性。此外,与血管活性肠肽(VIP)具有相当同源性的PACAP27表现出与VIP相似的血管降压活性,但腺苷酸环化酶刺激活性比VIP大约高1000倍。